Skip to main content

Table 2 Univariate and multivariate analysis of parameters associated with resectability after GBNAT

From: Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy

Parameters

Non-resectable

Resectable

Univariate

Multivariate

 

N = 24

N = 17

P

OR

95% CI

P

Age

≥60y/o

18

12

0.735

0.939

0.876-1.00

0.075

 

<60y/o

6

5

    

CCRT

Yes

6

7

0.273

   
 

Nil

18

10

    

Tumor location

Tail

0

6

<0.001

50

1.218- >100

0.039

 

Head/body

24

11

    

CEA(post-GBNAT)

<4.9

13

7

0.280

   
 

≥4.9

11

10

    

CEA decrease (post-GBNAT)

Yes

10

8

0.821

   
 

Nil

14

9

    

CA199 (post-GBNAT)

<152

9

13

0.007

14.686

1.114-193.6

0.041

 

≥152

15

4

    

CA199 decrease (post-GBNAT)

Yes

11

14

0.008

66.67

0.416- >100

0.105

 

Nil

13

3

    

CA125(post-GBNAT)

<32.8

12

9

0.790

   
 

≥32.8

12

8

    

CA125 decrease (post-GBNAT)

Yes

14

4

0.026

8.547

0.138- >100

0.308

 

Nil

10

13

    
  1. Bold letter means the p-values less than 0.05.